Add to Calendar
When:
September 30, 2021 @ 7:00 pm – 8:00 pm
America/New York Timezone
2021-09-30T19:00:00-04:00
2021-09-30T20:00:00-04:00
Where:
Zoom webinar
Cost:
Free
Contact:
Alliance to Cure Cavernous Malformation
On September 30th at 7 pm ET, 4 pm PT, please join Dr. Lisa Boyette, Recursion Pharmaceuticals’ Senior Director of Medical Affairs, who will be sharing details of the new REC-994 trial for cavernous malformation. REC-994 is the first industry-sponsored medicine to reach trials for our families, and we are thrilled to share information about the Phase 2 launch with our community. Dr. Boyette will provide an overview of clinical trials in general and will offer specifics of the REC-994 trial, including the nature of the medicine, where the first sites will be, and who and how many will be eligible to participate.
